Global efforts to strengthen infectious disease prevention and treatment are driving the transformation of the Anti-Infective Agents Industry. Key growth factors include the increasing burden of infectious diseases, rising prevalence of drug-resistant microorganisms, and growing demand for advanced antibacterial, antiviral, antifungal, and antiparasitic therapies that support patient care...